Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
138M
-
Number of holders
-
293
-
Total shares
-
69.2M
-
Shares change
-
+1.26M
-
Total reported value, excl. options
-
$3.18B
-
Value change
-
+$35.9M
-
Put/Call ratio
-
1.19
-
Number of buys
-
148
-
Number of sells
-
-131
-
Price
-
$45.99
Significant Holders of ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (ARWR) as of Q1 2022
304 filings reported holding ARWR - ARROWHEAD PHARMACEUTICALS, INC. - Common Stock as of Q1 2022.
ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (ARWR) has 293 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 69.2M shares
of 138M outstanding shares and own 50.24% of the company stock.
Largest 10 shareholders include BlackRock Inc. (12.2M shares), VANGUARD GROUP INC (9.72M shares), STATE STREET CORP (4.68M shares), JPMORGAN CHASE & CO (2.92M shares), ALLIANCEBERNSTEIN L.P. (2.76M shares), Invesco Ltd. (2.33M shares), GEODE CAPITAL MANAGEMENT, LLC (1.85M shares), FMR LLC (1.4M shares), NORTHERN TRUST CORP (1.39M shares), and CREDIT SUISSE AG/ (1.28M shares).
This table shows the top 293 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.